Patient selection criteria for liver transplantation

Minerva Chirurgica

Volumn 58, Issue 5, 2003, Pages 635-648

  Yu, A S ^a,b,c   Keeffe, E B ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Liver failure; Liver transplantation; Living donors; Tissue donors

Indexed keywords

CADAVER DONOR; DISEASE SEVERITY; GRAFT SURVIVAL; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; ORGAN DONOR; PATIENT SELECTION; POSTOPERATIVE PERIOD; RELATIVE; RESOURCE ALLOCATION; REVIEW; SURVIVAL; UNITED STATES;

HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; PATIENT SELECTION; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT;

EID: 0347597865     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Keeffe EB. Selection of patients for liver transplantation. In: Maddrey WC, Schiff ER, Sorrell MF, editors. Transplantation of the liver. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001.p.5-34.
2. Yoshida EM, Lake JR. Selection of patients for liver transplantation in 1997 and beyond. Clin Liver Dis 1997;1:247-61.
3. Seaberg EC, Belle SH, Beringer KC, Schivins JL, Detre KM. Liver transplantation in the United States from 1987-1998: updated results from the Pitt-UNOS liver transplant registry. In: Cecka JM, Terasaki PI, editors. Clinical transplants 1998. Los Angeles: UCLA Tissue Typing Laboratory; 1999.p.17-37.
4. Starzl TE. History of liver and other splanchnic organ transplantation. In: Busuttil RW, Klintmalm GB, editors. Transplantation of the liver. Philadelphia: W.B. Saunders; 1996.p.3-22.
5. Smith CM, Davies DB, McBride MA. Liver transplantation in the United States: a report from the Organ Procurement and Transplantation Network. In: Cecka JM, Terasaki PI, editors. Clinical Transplants 1998. Los Angeles: UCLA Tissue Typing Laboratory; 2001.p.19-30.
6. Yu AS, Ahmed A, Keeffe EB. Liver transplantation: evolving patient selection criteria. Can J Gastroenterol 2001;15:729-38.
7. Wiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL et al. Recent advances in liver transplantation. Mayo Clin Proc 2003;78:197-210.
8. U.S. Scientific Registry (UNOS). Richmond, VA: United Network for Organ Sharing; 2003.
9. Bravata DM, Olkin I, Barnato AE, Keeffe EB, Owens DK. Health-related quality of life after liver transplantation: A meta-analysis. Liver Transpl Surg 1999;5:318-31.
10. Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997;3:628-37.
11. Showstack J, Katz PP, Lake JR, Brown RS Jr, Dudley RA, Belle S et al. Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. JAMA 1999;281:1381-6.
12. Gilbert JR, Pascual M, Schoenfeld DA, Rubin RH, Delmonico FL, Cosimi AB. Evolving trends in liver transplantation: an outcome and charge analysis. Transplantation 1999;67:246-53.
13. Davern TL, Lake JR. Recurrent disease after liver transplantation. Semin Gastrointest Dis 1998;9:86-109.
14. McDiarmid SV. Liver transplantation for metabolic disease. In: Busuttil RW, Klintmalm GB, editors. Transplantation of the liver. Philadelphia: W.B. Saunders; 1996.p.198-215.
15. th ed. Philadelphia: Harcourt Health Sciences Companies; 2002.p.1617-56.
16. Keeffe BG, Valantine H, Keeffe EB. Detection and treatment of coronary artery disease in liver transplant candidates. Liver Transpl 2001;7:755-61.
17. Norman DJ. Allocation of livers for liver transplantation: ethics and politics. Clin Liver Dis 1997;1:281-6.
18. Burdick JF, Klein AS, Harper AM. The debate over liver allocation in the United States: the UNOS perspective. In: Cecka JM, Terasaki PI, editors. Clinical Transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory; 1997.p.322-4.
19. Bzeizi KI, Jalan R, Plevris JN, Hayes PC. Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. Liver Transpl Surg 1997;3:137-48.
20. Busuttil RW, Shaked A, Millis JM, Jurim O, Colquhoun SD, Shackleton CR et al. One thousand liver transplants. The lessons learned. Ann Surg 1994;219:490-7.
21. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996;62:1246-51.
22. Detre KM, Lombardero M, Belle S, Beringer K, Breen T, Daily OP et al. Influence of donor age on graft survival after transplantation - United Network for Organ Sharing Registry. Liver Transpl Surg 1995;1:311-9.
23. Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J et al. Donor age and outcome of liver transplantation. Hepatology 1996;24:89-96.
24. Yersiz H, Shaked A, Olthoff K, Imagawa D, Shackleton C, Martin P et al. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 1995;60:790-4.
25. Washburn WK, Johnson LB, Lewis WD, Jenkins RL. Graft function and outcome of older (>or=60 years) donor livers. Transplantation 1996;61:1062-6.
26. Emre S, Schwartz ME, Altaca G, Sethi P, Fiel MI, Guy SR et al. Safe use of hepatic allografts from donors older than 70 years. Transplantation 1996;62:62-5.
27. Dodson SF, Bonham CA, Geller DA, Cacciarelli TV, Rakela J, Fung JJ. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999;68:1058-61.
28. Holt D, Thomas R, Van Thiel D, Brems JJ. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation. Arch Surg 2002;137:572-5.
29. Roque-Afonso AM, Feray C, Samuel D, Simoneau D, Roche B, Emile JF et al. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors. Gut 2002;50:95-9.
30. Uemoto S, Sugiyama K, Marusawa H, Inomata Y, Asonuma K, Egawa H et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998;65:494-9.
31. Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E et al. Transmission of hepatitis B infection from hepatitis B core antibody-positive liver allografts is prevented by lamivudine therapy. Liver Transpl 2001;7:513-7.
32. Loss GE, Mason AL, Blazek J, Dick D, Lipscomb J, Guo L et al. Transplantation of livers from HBc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results. Clin Transplant 2001;15 Suppl 6:55-8.
33. Dodson SF, Issa S, Araya V, Gayowski T, Pinna A, Eghtesad B et al. Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation 1997;64:1582-4.
34. Vargas HE, Laskus T, Wang LF, Lee R, Radkowski M, Dodson F et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology 1999;117:149-53.
35. Marroquin CE, Marino G, Kuo PC, Plotkin JS, Rustgi VK, Lu AD et al. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl 2001;7:762-8.
36. Velidedeoglu E, Desai NM, Campos L, Olthoff KM, Shaked A, Nunes F et al. The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation 2002;73:582-7.
37. Busuttil RW, Goss JA. Split liver transplantation. Ann Surg 1999;229:313-21.
38. Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 1990;212:368-75.
39. Rela M, Vougas V, Muiesan P, Vilca-Melendez H, Smyrniotis V, Gibbs P et al. Split liver transplantation: King's College Hospital experience. Ann Surg 1998;227:282-8.
40. Ghobrial RM, Yersiz H, Farmer DG, Amersi F, Goss J, Chen P et al. Predictors of survival after in vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg 2000;232:312-23.
41. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997;276:60-6.
42. Francavilla A, Zeng Q, Polimeno L, Carr BI, Sun D, Porter KA et al. Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration. Hepatology 1994;19:210-6.
43. Shiffman ML, Brown RS Jr, Olthoff KM, Everson G, Miller C, Siegler M et al. Living donor liver transplantation: summary of a conference at The National Institutes of Health. Liver Transpl 2002;8:174-88.
44. Raia S, Nery JR, Mies S. Liver transplantation from live donors. Lancet 1989;2:497.
45. Inomata Y, Tanaka K, Okajima H, Uemoto S, Ozaki N, Egawa H et al. Living related liver transplantation for children younger than one year old. Eur J Pediatr Surg 1996;6:148-51.
46. Hashikura Y, Makuuchi M, Kawasaki S, Matsunami H, Ikegami T, Nakazawa Y et al. Successful living-related partial liver transplantation to an adult patient. Lancet 1994;343:1233-4.
47. Marcos A, Ham JM, Fisher RA, Olzinski AT, Posner MP. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl 2000;6:296-301.
48. Marcos A. Right lobe living donor liver transplantation: a review. Liver Transpl 2000;6:3-20.
49. Lo CM, Fan ST, Liu CL, Wei WI, Lo RJ, Lai CL et al. Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg 1997;226:261-9.
50. Trotter JF, Wachs M, Trouillot T, Steinberg T, Bak T, Everson GT et al. Evaluation of 100 patients for living donor liver transplantation. Liver Transpl 2000;6:290-5.
51. Olofsson BO, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 2002;73:745-51.
52. Suhr OB, Ericzon BG, Friman S. Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transpl 2002;8:787-94.
53. Bittencourt PL, Couto CA, Farias AQ, Marchiori P, Bosco Massarollo PC et al. Results of liver transplantation for familial amyloid polyneuropathy type I in Brazil. Liver Transpl 2002;8:34-9.
54. Hemming AW, Cattral MS, Chari RS, Greig PD, Lilly LB, Ashby P et al. Domino liver transplantation for familial amyloid polyneuropathy. Liver Transpl Surg 1998;4:236-8.
55. Dyer PA, Bobrow M. Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathy. Unrelated Live Transplant Regulatory Authority (ULTRA). Transplantation 1999;67:1202.
56. Sterling RK, Fisher RA. Liver transplantation. Living donor, hepatocyte, and xenotransplantation. Clin Liver Dis 2001;5:431-60.
57. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-45.
58. Bernuau J, Samuel D, Durand F et al. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V (FV) below 50% of normal: a prospective study [Abstract]. Hepatology 1991;14:49A.
59. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000;6:163-9.
60. Riordan SM, Williams R. Use and validation of selection criteria for liver transplantation in acute liver failure. Liver Transpl 2000;6:170-3.
61. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989;10:1-7.
62. Kim WR, Therneau TM, Wiesner RH, Poterucha JJ, Benson JT, Malinchoc M et al. A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc 2000;75:688-94.
63. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
64. Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983;308:1-7.
65. Markus BH, Dickson ER, Grambsch PM, Fleming TR, Mazzaferro V, Klintmalm GB et al. Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 1989;320:1709-13.
66. Shapiro JM, Smith H, Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 1979;20:137-40.
67. Wiesner RH, Porayko MK, Dickson ER, Gores GJ, LaRusso NF, Hay JE et al. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1992;16:1290-9.
68. Klion FM, Fabry TL, Palmer M, Schaffner F. Prediction of survival of patients with primary biliary cirrhosis. Examination of the Mayo Clinic model on a group of patients with known endpoint. Gastroenterology 1992;102:310-3.
69. Grambsch PM, Dickson ER, Kaplan M, LeSage G, Fleming TR, Langworthy AL. Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability. Hepatology 1989;10:846-50.
70. Gilroy RK, Lynch SV, Strong RW, Kerlin P, Balderson GA, Stuart KA et al. Confirmation of the role of the Mayo Risk Score as a predictor of resource utilization after orthotopic liver transplantation for primary biliary cirrhosis. Liver Transpl 2000;6:749-52.
71. Kim WR, Wiesner RH, Therneau TM, Poterucha JJ, Porayko MK, Evans RW et al. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology 1998;28:33-8.
72. Kim WR, Dickson ER. Timing of liver transplantation. Semin Liver Dis 2000;20:451-64.
73. Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Benson JT, Krom RA et al. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl 2000;6:489-94.
74. Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992;103:1893-901.
75. Wee A, Ludwig J, Coffey RJ Jr, LaRusso NF, Wiesner RH. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol 1985;16:719-26.
76. Farges O, Malassagne B, Sebagh M, Bismuth H. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery 1995;117:146-55.
77. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;79:200-6.
78. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980;21:870-7.
79. Iwatsuki S, Todo S, Marsh JW, Madariaga JR, Lee RG, Dvorchik I et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998;187:358-64.
80. De Vreede I, Steers JL, Burch PA, Rosen CB, Gunderson LL, Haddock MG et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000;6:309-16.
81. Talwalkar JA, Seaberg E, Kim WR, Wiesner RH. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and child-pugh score. Liver Transpl 2000;6:753-8.
82. Abad-Lacruz A, Cabre E, Gonzalez-Huix F, Fernandez-Banares F, Esteve M, Planas R et al. Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child-Pugh score in nonbleeding advanced cirrhotics. Am J Gastroenterol 1993;88:382-7.
83. Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001;34:46-52.
84. Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E et al. and UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8:851-8.
85. Freeman RB Jr. In pursuit of the ideal liver allocation model. Liver Transpl 2002;8:799-801.
86. Anonymous. Organ procurement and transplantation network - HRSA. Final rule with comment period. Federal Register 1998;63:16296-338.
87. Institute of Medicine. Analysis of waiting time. In: Committee on Organ Transplantation. Assessing current policies and the potential impact of the DHHS final rule. Washington, DC: National Academy Press; 1999.p.57-78.
88. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-71.
89. Brown RS Jr, Kumar KS, Russo MW, Kinkhabwala M, Rudow DL, Harren P et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002;8:278-84.
90. Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003;9:12-8.
91. Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology 2001;33:473-5.
92. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001;7:567-80.
93. Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003;9:117-23.
94. Onaca NN, Levy MF, Netto GJ, Thomas MJ, Sanchez EQ, Chinnakotla S et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant 2003;3:626-30.
95. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003;9:473-6.
96. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002;35:1179-85.